cartridgebas
random
access
molecular
technolog
abil
rapidli
detect
multipl
target
singl
low
complex
test
format
becom
wide
avail
diagnost
microbiolog
laboratori
cost
benefit
implement
new
technolog
rapid
diagnost
test
fulli
establish
may
depend
significantli
patient
laboratori
hospit
characterist
cost
per
test
random
access
molecular
platform
usual
cartridgebas
significantli
higher
cost
batch
molecular
test
multipl
specimen
held
laboratori
process
batch
batch
test
minimis
cost
effici
use
reagent
equip
staff
time
howev
may
also
result
slower
laboratori
turnaround
time
tat
lead
delay
clinic
decisionmak
patient
batch
test
also
usual
requir
higher
level
laboratori
scientif
expertis
oversight
potenti
increas
overal
laboratori
cost
delay
result
laboratori
may
flow
effect
hospit
term
antibiot
use
durat
inpati
stay
use
isol
room
result
increas
hospit
cost
time
identif
specif
pathogen
lead
either
cessat
antibiot
direct
antibiot
therapi
deliv
time
manner
rapid
accur
diagnosi
play
key
role
optimis
antimicrobi
stewardship
outcom
rapid
test
may
also
improv
use
respiratori
isol
room
either
appropri
isol
patient
respiratori
pathogen
earli
discharg
isol
patient
neg
test
result
evid
rapid
test
respiratori
virus
decreas
durat
antibiot
use
hospit
length
stay
lo
isol
bed
lo
particularli
patient
influenza
virus
howev
find
uniform
may
impact
type
popul
eg
paediatr
vs
adult
underli
comorbid
clinic
set
preval
influenza
versu
respiratori
pathogen
whether
respiratori
infect
eg
bacteri
pneumonia
present
studi
specif
examin
impact
broad
respiratori
pathogen
panel
find
favour
term
hospit
resourc
utilis
improv
clinic
manag
howev
studi
perform
paediatr
hospit
set
rel
pauciti
evid
regard
impact
random
access
respiratori
test
adult
object
studi
determin
whether
deploy
random
access
cartridgebas
molecular
assay
biofir
filmarray
respiratori
panel
mediums
diagnost
laboratori
serv
tertiari
adult
hospit
impact
laboratori
tat
workflow
compar
standard
batch
molecular
test
respiratori
target
prospect
measur
clinic
resourc
utilis
includ
hospit
isol
bed
lo
prospect
studi
royal
melbourn
hospit
rmh
parkvil
australia
compar
clinic
hospit
laboratori
paramet
week
august
octob
implement
biofir
filmarray
respiratori
panel
biomerieux
franc
diagnosi
respiratori
pathogen
biofir
filmarray
respiratori
panel
cartridgebas
multiplex
molecular
assay
capabl
detect
target
includ
influenza
strain
influenza
b
parainfluenza
adenoviru
coronaviru
human
metapneumoviru
respiratori
syncyti
viru
rhinovirusenteroviru
bordetella
pertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
sever
studi
demonstr
high
clinic
analyt
sensit
specif
compar
standard
diagnost
test
algorithm
prior
introduct
filmarray
panel
nation
associ
test
author
nata
approv
inhous
realtim
polymeras
chain
reaction
pcr
detect
influenza
b
respiratori
syncyti
viru
rsv
rhinoviru
routin
use
detect
respiratori
virus
primer
probe
influenza
suppli
biosearch
technolog
usa
rna
extract
use
commerci
kit
advanc
xl
biorobot
qiagen
germani
accord
manufactur
instruct
run
appli
biosystem
usa
eight
sampl
process
singl
run
follow
implement
filmarray
assay
run
sampl
order
facilit
direct
comparison
assay
verif
purpos
rmh
major
tertiari
hospit
melbourn
australia
busi
admissionsyear
emerg
depart
ed
serv
melbourn
metropolitan
area
microbiolog
laboratori
predominantli
serv
rmh
approxim
workload
oper
hour
per
day
day
per
week
hour
one
scientist
avail
laboratori
work
prioritis
accord
clinic
urgenc
studi
nasopharyng
swab
test
patient
admit
rmh
h
request
respiratori
pcr
patient
haematolog
bone
marrow
transplant
medic
oncolog
unit
exclud
often
treat
via
febril
neutropenia
guidelin
protocol
like
affect
hospit
stay
clinic
demograph
data
record
standardis
case
report
form
crf
includ
admiss
discharg
date
time
use
respiratori
isol
room
time
specimen
receipt
laboratori
process
start
finish
time
time
result
releas
time
respiratori
pcr
result
view
clinician
hospit
electron
patholog
record
time
motion
studi
done
record
handson
laboratori
work
time
time
step
assay
record
standardis
crf
time
motion
studi
laboratori
staff
member
use
timer
stopwatch
record
time
minut
second
step
inhous
pcr
includ
record
total
time
access
set
specimen
extract
prepar
sampl
amplif
read
report
result
sinc
inhous
pcr
assay
batch
total
time
individu
specimen
studi
calcul
divid
overal
time
entir
batch
number
sampl
batch
filmarray
assay
time
taken
access
set
load
test
report
result
record
individu
specimen
preimplement
phase
nasopharyng
specimen
batch
access
extract
amplif
stage
perform
dedic
molecular
scientist
inhous
assay
run
per
weekday
result
releas
late
afternoon
postimplement
phase
specimen
split
inhous
pcr
assay
perform
filmarray
process
soon
practic
h
per
day
avail
microbiologist
result
preimplement
postimplement
period
report
directli
hospit
electron
patholog
record
notifi
hospit
infect
prevent
team
fax
pager
within
min
discrep
result
two
assay
sent
test
extern
laboratori
outcom
measur
includ
laboratori
tat
time
arriv
specimen
laboratori
releas
electron
result
clinician
staff
handson
time
time
result
check
treat
clinician
hospit
lo
isol
bed
lo
calcul
compar
preimplement
postimplement
group
studi
power
detect
differ
laboratori
tat
least
h
differ
hospit
lo
isol
bed
lo
least
h
power
confid
base
previou
estim
paramet
due
nonparametr
distribut
continu
outcom
measur
collect
median
valu
calcul
wilcoxonrank
sum
test
use
determin
clinic
signific
differ
categor
variabl
chisquar
test
use
visual
test
linear
perform
remov
data
outlier
run
univari
linear
regress
model
factor
predict
hospit
lo
isol
bed
lo
factor
p
along
clinic
relev
factor
determin
priori
incorpor
final
multivari
model
statist
calcul
done
stata
statacorp
usa
studi
approv
rmh
human
research
ethic
committe
hrec
approv
number
preimplement
studi
period
preimplement
period
nasopharyng
specimen
request
respiratori
test
receiv
exclud
studi
fig
postimplement
studi
period
postimplement
period
patient
specimen
receiv
exclud
thu
final
analysi
patient
includ
preimplement
group
includ
postimplement
group
group
similar
across
rang
baselin
characterist
present
tabl
two
combin
studi
period
inhous
respiratori
pcr
yield
posit
result
case
proport
influenza
case
detect
higher
preimplement
postimplement
period
versu
respect
p
postimplement
period
filmarray
respiratori
panel
detect
target
case
compar
inhous
pcr
detect
target
case
increas
yield
larg
due
detect
target
includ
inhous
pcr
panel
howev
four
specimen
discrep
result
occur
involv
pathogen
includ
inhous
panel
influenza
rhinoviru
rsv
supplementari
tabl
appendix
addit
test
support
filmarray
result
two
four
specimen
inhous
pcr
result
one
one
specimen
indetermin
median
laboratori
tat
h
use
filmarray
h
inhous
pcr
p
filmarray
requir
approxim
staff
handson
time
batch
inhous
assay
min
vs
min
respect
p
overal
laboratori
tat
impact
earlier
process
filmarray
process
commenc
median
h
arriv
laboratori
compar
h
inhous
assay
p
reduc
laboratori
tat
reflect
earlier
avail
result
clinician
tabl
preimplement
period
specimen
result
avail
patient
discharg
hospit
median
durat
laboratori
receipt
specimen
clinician
check
result
patholog
viewer
clinic
tat
h
rang
h
comparison
specimen
result
avail
discharg
postimplement
period
p
clinic
tat
median
h
rang
h
p
despit
signific
reduct
laboratori
clinic
tat
signific
chang
hospit
lo
isol
bed
lo
preimplement
postimplement
period
tabl
also
differ
hospit
isol
bed
lo
hospit
lo
day
admit
ed
posit
test
result
posit
test
influenza
univari
multivari
regress
model
perform
identifi
factor
predict
hospit
lo
isol
bed
lo
tabl
ed
gener
medicin
admiss
associ
shorter
longer
hospit
lo
respect
ed
admiss
also
associ
reduct
isol
bed
lo
although
admiss
unit
impact
outcom
posit
influenza
result
also
associ
shorter
hospit
isol
lo
knowledg
one
first
prospect
studi
measur
laboratori
health
servic
outcom
filmarray
implement
diagnost
laboratori
adult
hospit
found
use
filmarray
significantli
increas
target
detect
compar
exist
inhous
respiratori
pcr
method
result
decreas
laboratori
clinic
tat
howev
find
translat
reduc
hospit
isol
bed
lo
filmarray
detect
target
sampl
compar
sampl
use
inhous
respiratori
pcr
similar
posit
rate
report
studi
adult
filmarray
implement
predominantli
due
broader
rang
respiratori
target
detect
filmarray
assay
preimplement
period
correspond
earlier
part
australian
winter
season
julyaugust
postimplement
period
correspond
latter
part
season
septemberoctob
found
detect
influenza
total
proport
respiratori
target
detect
lower
postimplement
compar
preimplement
fig
flow
diagram
describ
process
select
appropri
specimen
studi
specimen
receiv
request
respiratori
pcr
assess
elig
preimplement
postimplement
period
specimen
exclud
patient
admit
oncolog
haematolog
bone
marrow
transplant
unit
hospit
length
stay
lo
greater
h
time
specimen
request
privat
patient
outpati
duplic
inappropri
specimen
nasopharyng
swab
aspir
accept
appli
exclus
specimen
includ
preimplement
phase
specimen
inhous
respiratori
pcr
perform
postimplement
phase
specimen
includ
follow
exclus
specimen
inhous
respiratori
pcr
filmarray
perform
period
along
studi
shown
earli
detect
influenza
like
influenc
healthcar
resourc
utilis
earlier
discharg
use
isol
room
note
decreas
hospit
isol
bed
lo
patient
posit
influenza
diagnosi
tabl
reduc
number
influenza
detect
postimplement
period
may
impact
abil
detect
health
servic
outcom
reduc
laboratori
clinic
tat
howev
still
note
chang
lo
postimplement
group
even
account
potenti
confound
studi
found
signific
decreas
laboratori
tat
respiratori
pathogen
test
median
h
factor
found
nonsignific
univari
analysi
includ
gender
admiss
acut
medic
unit
admiss
infecti
diseas
unit
admiss
respiratori
unit
shift
specimen
receiv
laboratori
b
preimplement
vs
postimplement
c
factor
found
nonsignific
univari
analysi
includ
gender
admiss
acut
medic
unit
admiss
infecti
diseas
unit
admiss
respiratori
unit
admiss
gener
medicin
unit
shift
specimen
receiv
laboratori
preimplement
period
h
postimplement
filmarray
period
also
significantli
reduc
clinic
tat
h
h
common
studi
evalu
filmarray
implement
found
significantli
larger
percentag
test
result
avail
clinician
prior
patient
discharg
hospit
compar
increas
chanc
laboratori
result
could
impact
patient
care
hospit
outcom
interestingli
tat
filmarray
hand
longer
report
laboratori
may
reduc
clinic
impact
rapid
test
median
tat
h
time
specimen
arriv
laboratori
result
report
compar
h
report
rappo
et
al
may
reflect
specif
condit
laboratori
lack
dedic
scientist
time
run
assay
work
hour
singl
scientist
microbiolog
laboratori
specimen
process
order
clinic
prioriti
given
actual
run
time
test
approxim
h
scope
decreas
laboratori
tat
filmarray
laboratori
best
knowledg
first
studi
report
time
motion
studi
laboratori
handson
work
time
filmarray
unexpectedli
found
littl
differ
handson
work
time
per
specimen
inhous
pcr
compar
highli
autom
cartridgebas
filmarray
assay
vs
min
per
sampl
like
batch
natur
inhous
pcr
test
increas
workflow
effici
also
note
measur
median
min
handson
work
time
filmarray
differ
min
claim
manufactur
although
filmarray
low
complex
individu
cartridgebas
natur
test
meant
singl
specimen
attend
sever
time
scientist
access
set
pcr
load
pcr
result
read
li
report
clinic
result
notif
present
studi
cost
per
individu
cartridg
filmarray
assay
au
comparison
approxim
cost
inhous
pcr
au
per
sampl
given
cost
differ
unlik
filmarray
respiratori
panel
test
could
justifi
cost
ground
routin
clinic
sampl
absenc
evid
test
result
improv
patient
care
clinic
outcom
find
reduc
clinic
tat
postimplement
period
statist
signific
impact
hospit
lo
differ
report
studi
implement
filmarray
institut
larger
retrospect
studi
children
conduct
children
healthcar
atlanta
filmarray
implement
associ
signific
decreas
vs
day
inpati
lo
patient
posit
test
result
although
clear
minor
differ
lo
approxim
h
would
signific
health
system
perspect
present
studi
power
detect
clinic
signific
differ
hospit
isol
lo
determin
priori
minimum
h
anoth
retrospect
studi
adult
conduct
new
york
presbyterian
hospitalweil
cornel
medic
centr
report
reduc
hospit
lo
patient
test
posit
influenza
control
confound
factor
median
tat
studi
report
posit
result
filmarray
result
h
shorter
tat
compar
tat
current
studi
h
may
increas
impact
health
servic
outcom
possibl
may
critic
laboratori
tat
need
reach
order
posit
impact
hospit
lo
hypothesis
would
reduct
isol
bed
lo
faster
avail
respiratori
pcr
result
howev
find
statist
signific
impact
isol
bed
usag
postimplement
period
unexpectedli
low
use
symptomsbas
isol
group
patient
test
respiratori
pathogen
tabl
may
reduc
power
detect
signific
chang
isol
bedday
brendish
et
al
also
report
chang
isol
bed
lo
randomis
control
trial
although
shorter
durat
deisol
patient
empir
isol
admiss
subsequ
test
neg
influenza
viru
hospit
isol
bed
polici
influenc
whether
rapid
microbiolog
test
posit
neg
impact
isol
bed
lo
interestingli
retrospect
studi
children
cohen
children
medic
centr
ny
filmarray
implement
result
signific
increas
use
isol
precaut
per
patient
day
compar
per
patient
day
preimplement
period
suggest
implement
result
appropri
use
patient
isol
room
potenti
prevent
hospit
transmiss
respiratori
target
assess
impact
reduc
laboratori
tat
antimicrobi
use
hospit
although
other
report
benefit
interestingli
recent
studi
impact
filmarray
test
amongst
adult
outpati
tertiari
hospit
found
influenza
diagnosi
respiratori
pathogen
detect
posit
impact
oseltamivir
prescript
reduc
antimicrobi
prescript
suggest
rapid
molecular
test
detect
narrow
spectrum
pathogen
might
costeffect
major
strength
studi
prospect
design
real
time
record
data
throughout
studi
period
singl
winter
season
also
formal
timeandmot
studi
time
accur
measur
handson
laboratori
scientist
work
time
assay
exclus
patient
admit
oncolog
unit
patient
admit
hospit
h
may
decreas
hospitalwid
applic
result
anoth
limit
studi
sampl
randomis
filmarray
test
versu
standard
inhous
test
may
minor
unrecognis
differ
patient
cohort
two
sequenti
studi
period
demonstr
introduct
highli
autom
cartridgebas
molecular
assay
respiratori
target
signific
impact
laboratori
tat
clinic
tat
avail
result
prior
patient
discharg
hospit
find
decreas
laboratori
clinic
tat
directli
result
reduc
hospit
lo
chang
use
isol
bed
given
increas
cost
test
unchang
laboratori
handson
work
time
lack
health
servic
impact
difficult
justifi
implement
rel
expens
test
without
evid
improv
clinic
outcom
whilst
simplist
point
view
shorter
laboratori
tat
result
shorter
hospit
lo
factor
contribut
lo
exampl
natur
histori
diseas
avail
senior
clinician
make
final
decis
patient
discharg
discharg
plan
requir
elucid
rel
contribut
differ
factor
lo
import
better
alloc
resourc
well
realis
need
deploy
new
assay
conjunct
increas
bedsid
resourc
futur
work
could
focu
reduc
laboratori
tat
work
close
hospit
antimicrobi
stewardship
team
infect
prevent
team
ensur
earlier
avail
laboratori
result
translat
direct
clinic
impact
conflict
interest
sourc
fund
studi
support
victor
hurley
research
grant
aid
royal
melbourn
hospit
parkvil
australia
author
state
conflict
interest
disclos
